Prospectus Supplement
(To Prospectus dated August 5, 2020)
$500,000,000
Common Stock
This prospectus supplement relates to the issuance and sale of shares of our common stock having an aggregate offering price of up to $500,000,000 from time to time through our sales agents, J.P. Morgan Securities LLC, Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, BNP Paribas Securities Corp. and TD Securities (USA) LLC. These sales, if any, will be made pursuant to the terms of an equity distribution agreement entered into between us and the sales agents on March 26, 2021. In the event that we amend the equity distribution agreement to permit any sales agents other than J.P. Morgan Securities LLC, Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, BNP Paribas Securities Corp. and TD Securities (USA) LLC to become party to the equity distribution agreement, we will file a prospectus supplement to reflect any additional sales agents.
Sales of shares of our common stock under this prospectus supplement, if any, may be made in privately negotiated transactions and/or any other method permitted by law, including block trades or sales deemed to be an “at the market” offering as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), which includes sales made directly on the New York Stock Exchange (the “NYSE”), sales made to or through a market maker other than on an exchange or sales through an electronic communications network. Each of the sales agents will make all sales using its commercially reasonable efforts consistent with its normal trading and sales practices on mutually agreed terms between the sales agents and us.
Our common stock trades on the NYSE under the symbol “MAC.” On March 25, 2021, the last reported sale price of our common stock on the NYSE was $12.14 per share. Our common stock has recently experienced significant price fluctuations. For example, between January 1, 2021 and March 22, 2021, the highest intra-day sale price of our common stock on the NYSE was $25.99 per share and the lowest intra-day sale price of our common stock on the NYSE was $10.31 per share. The high of $25.99 occurred on January 27, 2021 when approximately 58,466,600 shares were traded. Our average daily trading volume between January 1, 2021 and March 22, 2021 was approximately 9,494,650 shares per day. During this time, we have not experienced any material changes in our financial condition or results of operations that explain such price volatility or increased trading volume.
We will pay each sales agent a commission that will not exceed, but may be lower than, 2% of the gross proceeds of the shares sold pursuant to the equity distribution agreement by such sales agent. The net proceeds from any sales under this prospectus supplement will be used as described under “Use of Proceeds” in this prospectus supplement.
In connection with the sale of common stock on our behalf, the sales agents may be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of the sales agents may be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to the sales agents against certain liabilities, including liabilities under the Securities Act.
We previously entered into an equity distribution agreement, dated February 1, 2021 (the “Prior Equity Distribution Agreement”), with Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as sales agents, and may continue to offer shares of our common stock having an aggregate offering price of up to $500,000,000 from time to time under the Prior Equity Distribution Agreement by means of a prospectus supplement, dated February 1, 2021 (the “Prior Prospectus Supplement”). Under the Prior Equity Distribution Agreement, from the period from February 1, 2021 through March 25, 2021, we issued approximately 36.0 million shares of our common stock, representing approximately $487.3 million of the available shares. This prospectus supplement does not terminate the Prior Equity Distribution Agreement and sales of the remaining unsold shares, if any, may be made pursuant to the Prior Prospectus Supplement and in accordance with the terms of the Prior Equity Distribution Agreement.
Investing in our common stock involves risks. See “Risk Factors” beginning on page S-3.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or passed on the adequacy or accuracy of prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
| | | | | | | | |
| | | | |
J.P. Morgan | | Deutsche Bank Securities | | Goldman Sachs & Co. LLC | | BNP PARIBAS | | TD Securities |
The date of this prospectus supplement is March 26, 2021.